J-CREST (Japan Clinical REtina STudy group), Kagoshima, Japan.
Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Yoshida, Japan.
J Diabetes Investig. 2024 Jul;15(7):882-891. doi: 10.1111/jdi.14195. Epub 2024 Mar 27.
AIMS/INTRODUCTION: To conduct a multicenter survey of visually impaired patients with diabetes mellitus (DM) and to identify the physical and ocular characteristics that lead to blindness in Japan.
Visually impaired patients with diabetes mellitus in Japan were divided into blind and low-vision groups according to the World Health Organization classification. Data on parameters related to diabetes mellitus and ocular complications in the right and left eyes were collected from 19 highly advanced medical facilities and compared between the two groups.
Among 408 visually impaired persons (blind group: 257, low-vision group: 151), 72.1% were under 70 years of age. The rates of neovascular glaucoma (NVG) (right eye, P = 0.041; left eye, P = 0.0031) or proliferative diabetic retinopathy (PDR) (right eye: P = 0.014, left eye: P = 0.0047) and the rate of proliferative membrane beyond half of the retinal area (right eye: P = 0.0263, left eye: P = 0.037) were significantly higher in the blind group. The direct cause of visual impairment was retinal atrophy, common in both groups. Neovascular glaucoma and diabetic macular edema were equally prevalent in the blind and low-vision groups, respectively.
In Japan, blind patients with diabetes mellitus are characterized by severe conditions such as neovascular glaucoma and progressive proliferative diabetic retinopathy upon their initial visit to an advanced care facility. These results highlight the importance of monitoring retinopathy through regular ophthalmological examinations, internal medicine, and appropriate therapeutic intervention.
目的/引言:对日本的糖尿病致盲患者进行多中心调查,明确导致其失明的身体和眼部特征。
根据世界卫生组织的分类,将日本的糖尿病致盲患者分为盲和低视力组。从 19 家高度先进的医疗机构收集了右眼和左眼与糖尿病和眼部并发症相关的参数数据,并对两组数据进行了比较。
在 408 名视力受损者(盲组:257 人,低视力组:151 人)中,72.1%年龄在 70 岁以下。新生血管性青光眼(NVG)(右眼,P=0.041;左眼,P=0.0031)或增生性糖尿病视网膜病变(PDR)(右眼:P=0.014,左眼:P=0.0047)的发生率以及增生性膜超过视网膜面积一半的发生率(右眼:P=0.0263,左眼:P=0.037)在盲组中明显更高。两组中视力损害的直接原因均为视网膜萎缩。新生血管性青光眼和糖尿病性黄斑水肿在盲组和低视力组中的发病率相当。
在日本,初次就诊于高级医疗机构的糖尿病致盲患者病情严重,存在新生血管性青光眼和进行性增生性糖尿病视网膜病变等情况。这些结果强调了通过定期眼科检查、内科治疗和适当的治疗干预来监测视网膜病变的重要性。